News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

XDx, Inc. Forms Deal with Laboratory Corporation of America Holdings (LabCorp) (LH)



2/7/2011 7:47:34 AM

BRISBANE, Calif.--(BUSINESS WIRE)--XDx, Inc., a molecular diagnostics company focused on noninvasive gene expression tests to monitor immune-mediated conditions, today announced that it has entered into a multi-year agreement with Laboratory Corporation of America Holdings (LabCorp; NYSE:LH) to provide heart transplant patients eligible for XDx’s AlloMap® test with the convenience of having their blood drawn at participating LabCorp sites across the United States.

Read at Xconomy
Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES